申请人:President and Fellows of Harvard College
公开号:EP3354265A1
公开(公告)日:2018-08-01
The invention relates to methods of treating protein degradation disorders, such as cellular proliferative disorders (e.g., cancer). The invention provides methods and pharmaceutical compositions for treating these diseases using aggresome inhibitors or combinations of aggresome inhibitors and proteasome inhibitors. The invention further relates to methods and pharmaceutical compositions for treating solid tumors. New HDAC/TDAC inhibitors and aggresome inhibitors are also provided as well as synthetic methodologies for preparing these compounds.
本发明涉及治疗蛋白质降解紊乱的方法,如细胞增殖紊乱(如癌症)。本发明提供了使用侵袭酶体抑制剂或侵袭酶体抑制剂和蛋白酶体抑制剂组合治疗这些疾病的方法和药物组合物。本发明还涉及治疗实体瘤的方法和药物组合物。本发明还提供了新的HDAC/TDAC抑制剂和侵袭体抑制剂以及制备这些化合物的合成方法。